Vaxcyte, Inc. (PCVX)
66.23
+2.55
(+4.00%)
USD |
NASDAQ |
Oct 20, 16:00
65.90
-0.33
(-0.50%)
After-Hours: 07:27
Vaxcyte Gross Profit (TTM) : -26.78M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.78M |
| March 31, 2026 | -25.84M |
| December 31, 2025 | -24.86M |
| September 30, 2025 | -19.84M |
| June 30, 2025 | -19.15M |
| March 31, 2025 | -17.64M |
| December 31, 2024 | -15.86M |
| September 30, 2024 | -14.02M |
| June 30, 2024 | -12.00M |
| March 31, 2024 | -10.92M |
| December 31, 2023 | -10.17M |
| September 30, 2023 | -9.523M |
| June 30, 2023 | -9.397M |
| March 31, 2023 | -9.16M |
| December 31, 2022 | -9.187M |
| Date | Value |
|---|---|
| September 30, 2022 | -8.093M |
| June 30, 2022 | -6.585M |
| March 31, 2022 | -5.289M |
| December 31, 2021 | -3.447M |
| September 30, 2021 | -2.573M |
| June 30, 2021 | -2.027M |
| March 31, 2021 | -1.559M |
| December 31, 2020 | -1.416M |
| September 30, 2020 | -1.416M |
| June 30, 2020 | -1.416M |
| March 31, 2020 | -1.316M |
| December 31, 2019 | -1.226M |
| September 30, 2019 | -0.894M |
| June 30, 2019 | -0.594M |
| March 31, 2019 | -0.294M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Moderna, Inc. | 280.00M |
| Vir Biotechnology, Inc. | 291.70M |
| Revolution Medicines, Inc. | -18.08M |
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Oncolytics Biotech, Inc. | -0.11M |